IL160016A0 - Osteogenic growth oligopeptides as stimulants of hematopoiesis - Google Patents

Osteogenic growth oligopeptides as stimulants of hematopoiesis

Info

Publication number
IL160016A0
IL160016A0 IL16001601A IL16001601A IL160016A0 IL 160016 A0 IL160016 A0 IL 160016A0 IL 16001601 A IL16001601 A IL 16001601A IL 16001601 A IL16001601 A IL 16001601A IL 160016 A0 IL160016 A0 IL 160016A0
Authority
IL
Israel
Prior art keywords
hematopoiesis
stimulants
osteogenic growth
oligopeptides
growth oligopeptides
Prior art date
Application number
IL16001601A
Other languages
English (en)
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Publication of IL160016A0 publication Critical patent/IL160016A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL16001601A 2001-07-29 2001-07-29 Osteogenic growth oligopeptides as stimulants of hematopoiesis IL160016A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IL2001/000700 WO2003011313A1 (en) 2001-07-29 2001-07-29 Osteogenic growth oligopeptides as stimulants of hematopoiesis

Publications (1)

Publication Number Publication Date
IL160016A0 true IL160016A0 (en) 2004-06-20

Family

ID=11043077

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16001601A IL160016A0 (en) 2001-07-29 2001-07-29 Osteogenic growth oligopeptides as stimulants of hematopoiesis

Country Status (19)

Country Link
US (1) US20050004037A1 (xx)
EP (1) EP1414480A1 (xx)
JP (1) JP2004536876A (xx)
KR (1) KR20040044436A (xx)
CN (1) CN1310672C (xx)
AU (1) AU2001282436B8 (xx)
BR (1) BR0117087A (xx)
CA (1) CA2456092A1 (xx)
CZ (1) CZ2004300A3 (xx)
EE (1) EE200400062A (xx)
HR (1) HRP20040135A2 (xx)
HU (1) HUP0400667A2 (xx)
IL (1) IL160016A0 (xx)
IS (1) IS7129A (xx)
MX (1) MXPA04000858A (xx)
NO (1) NO20040378L (xx)
NZ (1) NZ530904A (xx)
SK (1) SK912004A3 (xx)
WO (1) WO2003011313A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102532261A (zh) * 2010-12-29 2012-07-04 中国医学科学院药物研究所 骨重建激活剂-酪脯肽及其药物组合物和用途
CN106726672A (zh) * 2016-12-29 2017-05-31 陕西慧康生物科技有限责任公司 一种化妆品组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) * 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5461034A (en) * 1989-02-23 1995-10-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Osteogenic growth polypeptides identified from regenerating bone marrow
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5154921A (en) * 1990-07-13 1992-10-13 Dana-Farber Cancer Institute, Inc. Promotion of maturation of hematopoietic progenitor cells
DE4240635C2 (de) * 1992-12-03 1997-07-10 Lothar Prof Dr Kanz Vermehrung hämatopoetischer Vorläuferzellen ex vivo sowieZusammensetzungen hämatopoetischer Wachstumsfaktoren
IL104954A (en) * 1993-03-04 2006-08-01 Yissum Res Dev Co Use of osteogenic oligopeptides in the preparation of pharmaceutical compositions for the treatment of bone diseases and some such novel oligopeptides, pharmaceutical compositions containing them and their preparation
EP0721780A3 (en) * 1994-12-16 1997-12-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Agent for promoting platelet and/or leukocyte production
CN1163262C (zh) * 1999-04-01 2004-08-25 上海益众生物技术有限公司 成骨生长肽药物组合物及制备方法和应用

Also Published As

Publication number Publication date
US20050004037A1 (en) 2005-01-06
SK912004A3 (en) 2004-07-07
BR0117087A (pt) 2004-08-03
IS7129A (is) 2004-01-28
KR20040044436A (ko) 2004-05-28
HRP20040135A2 (en) 2005-02-28
AU2001282436B8 (en) 2008-05-01
EP1414480A1 (en) 2004-05-06
EE200400062A (et) 2004-06-15
CA2456092A1 (en) 2003-02-13
WO2003011313A1 (en) 2003-02-13
CZ2004300A3 (cs) 2005-03-16
JP2004536876A (ja) 2004-12-09
NO20040378L (no) 2004-03-26
HUP0400667A2 (hu) 2004-12-28
CN1551779A (zh) 2004-12-01
MXPA04000858A (es) 2005-06-06
WO2003011313A8 (en) 2004-04-08
NZ530904A (en) 2005-09-30
CN1310672C (zh) 2007-04-18
AU2001282436B2 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
EP1385862A4 (en) VASCULAR ENDOTHEL GROWTH FACTOR 2
HUP0402396A3 (en) Ophtalmic compositions comprising ascomycin
GB0206364D0 (en) Arthropodicidal compositions
EG23126A (en) Novel fungicial compositions
AU7315701A (en) Optically pure(-) clethodim, compositions and methods for controlling plant growth comprising the same
EP1534308A4 (en) PEPTIDES WITH INHIBITORY ACTION OF GROWTH
GB0114532D0 (en) Novel compositions
GB0117171D0 (en) Plant
IL160016A0 (en) Osteogenic growth oligopeptides as stimulants of hematopoiesis
PL367966A1 (en) Osteogenic growth oligopeptides as stimulants of hematopoiesis
IL158279A0 (en) Plant invigorator
GB2376401B (en) Self-watering plant pot
GB0114996D0 (en) Improvements to plant pots
TW499838U (en) Improved structure of water-absorbent flowerpot
AU149373S (en) Plant pot
AU149376S (en) Plant pot
AU149377S (en) Plant pot
AU149378S (en) Plant pot
AU149026S (en) Plant pot
AU149375S (en) Plant pot
AU146839S (en) Plant pot
AU149374S (en) Plant pot
GB0110498D0 (en) Improved plant propagator
GB0122102D0 (en) Chamber for growing plants
GB0102872D0 (en) Garden cloche